Page last updated: 2024-11-03

prochlorperazine and Idiopathic Parkinson Disease

prochlorperazine has been researched along with Idiopathic Parkinson Disease in 9 studies

Prochlorperazine: A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612)
prochlorperazine : A member of the class of phenothiazines that is 10H-phenothiazine having a chloro substituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position.

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19909 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DELAY, J1
DENIKER, P1
THUILLIER, J1
FREYHAN, FA1
STRATAS, NE1
PHILLIPS, RD1
WALKER, PA1
SANDIFER, MG1
BORENSTEIN, P1
DABBAH, M1
BLES, G1
Sheppard, C1
Merlis, S1
Stephen, PJ1
Williamson, J1
Simon, P1
Malatray, J1
Boissier, JR1
Markham, CH1
Denber, HC1
Mohr, CP1

Trials

1 trial available for prochlorperazine and Idiopathic Parkinson Disease

ArticleYear
Mefexamide as an antiparkinson drug. (A double-blind study).
    Diseases of the nervous system, 1969, Volume: 30, Issue:4

    Topics: Amides; Clinical Trials as Topic; Extrapyramidal Tracts; Female; Glycolates; Humans; Parasympatholyt

1969

Other Studies

8 other studies available for prochlorperazine and Idiopathic Parkinson Disease

ArticleYear
[Similarity of the neurological complications of prochlorperazine with various post-encephalitic disorders].
    Annales medico-psychologiques, 1957, Volume: 115, Issue:3

    Topics: Diagnosis, Differential; Humans; Nervous System Diseases; Parkinson Disease; Phenothiazines; Prochlo

1957
[Psychomotility, extrapyramidal syndrome and mode of action of neuroleptic therapies; chlorpromazine, reserpine and prochlorperazine].
    Der Nervenarzt, 1957, Nov-20, Volume: 28, Issue:11

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans

1957
A study of drug-induced parkinsonism.
    Diseases of the nervous system, 1963, Volume: 24

    Topics: Chlorpromazine; Humans; Mental Disorders; Parkinson Disease; Parkinsonian Disorders; Prochlorperazin

1963
[Apropos of the ultimate specificity of terrain in the appearance of extrapyramidal syndromes induced by neuroleptic agents].
    Annales medico-psychologiques, 1962, Volume: 120(2)

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Extrapyramidal Tracts; Haloperidol; Humans; Parkinson

1962
Drug-induced extrapyramidal symptoms: their incidence and treatment.
    The American journal of psychiatry, 1967, Volume: 123, Issue:7

    Topics: Chlorpromazine; Chlorprothixene; Extrapyramidal Tracts; Female; Fluphenazine; Humans; Male; Parasymp

1967
Drug-induced parkinsonism in the elderly.
    Lancet (London, England), 1984, Nov-10, Volume: 2, Issue:8411

    Topics: Aged; Antipsychotic Agents; Diagnosis, Differential; Female; Humans; Parkinson Disease; Parkinson Di

1984
Antagonism by amantadine of prochlorpemazine-induced catalepsy.
    The Journal of pharmacy and pharmacology, 1970, Volume: 22, Issue:7

    Topics: Amantadine; Animals; Barbiturates; Behavior, Animal; Catalepsy; Humans; Mice; Parkinson Disease; Pen

1970
The "on-off" side effect of L-DOPA.
    Advances in neurology, 1974, Volume: 5

    Topics: Age Factors; Amitriptyline; Aromatic Amino Acid Decarboxylase Inhibitors; Athetosis; Carbidopa; Cate

1974